HMPC: overview of assessment work - priority list
Submitted by Anonymous (not verified) on 2 October 2025 - 13:08
HMPC: overview of assessment work - priority list
Minutes - Enpr-EMA Coordinating Group & networks meeting - June 2025
Submitted by Anonymous (not verified) on 2 October 2025 - 12:53
Minutes - Enpr-EMA Coordinating Group & networks meeting - June 2025
Advice on end-of-year submission dates for type I variations in 2025
Submitted by Anonymous (not verified) on 2 October 2025 - 10:55
Advice on end-of-year submission dates for type I variations in 2025
Products Management Services (PMS) - Implementation of International Organization for Standardization (ISO) standards for the identification of medicinal products (IDMP) in Europe - Chapter 1: Registration requirements
Submitted by Anonymous (not verified) on 2 October 2025 - 9:18
Products Management Services (PMS) - Implementation of International Organization for Standardization (ISO) standards for the identification of medicinal products (IDMP) in Europe - Chapter 1: Registration requirements
Organisation chart: Advisory functions
Submitted by Anonymous (not verified) on 1 October 2025 - 16:00
Organisation chart: Advisory functions
Human medicines European public assessment report (EPAR): Nidlegy, bifikafusp alfa,onfekafusp alfa, Status: Application withdrawn
Submitted by Anonymous (not verified) on 1 October 2025 - 15:06
Human medicines European public assessment report (EPAR): Nidlegy, bifikafusp alfa,onfekafusp alfa, Status: Application withdrawn
Paediatric clinical trials
Submitted by Anonymous (not verified) on 1 October 2025 - 13:47
Paediatric clinical trials
Human medicines European public assessment report (EPAR): Farydak, panobinostat, Date of authorisation: 28/08/2015, Revision: 14, Status: Authorised
Submitted by Anonymous (not verified) on 1 October 2025 - 13:32
Human medicines European public assessment report (EPAR): Farydak, panobinostat, Date of authorisation: 28/08/2015, Revision: 14, Status: Authorised
Information on the Member States requirement for the nomination of a pharmacovigilance (PhV) contact person at national level
Submitted by Anonymous (not verified) on 1 October 2025 - 13:15
Information on the Member States requirement for the nomination of a pharmacovigilance (PhV) contact person at national level
In-use stability testing of veterinary medicinal products - Scientific guideline
Submitted by Anonymous (not verified) on 1 October 2025 - 8:44
In-use stability testing of veterinary medicinal products - Scientific guideline